-
1
-
-
33751009646
-
What do we know about the mechanisms of aromatase inhibitor resistance?
-
Chen S, Masri S, Wang X, Phung S, Yuan YC, Wu X. What do we know about the mechanisms of aromatase inhibitor resistance? J Steroid Biochem Mol Biol 2006; 102:232-40.
-
(2006)
J Steroid Biochem Mol Biol
, vol.102
, pp. 232-240
-
-
Chen, S.1
Masri, S.2
Wang, X.3
Phung, S.4
Yuan, Y.C.5
Wu, X.6
-
2
-
-
0027157709
-
Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture
-
Santner SJ, Chen S, Zhou D, Korsunsky Z, Martel J, Santen RJ. Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. J Steroid Biochem Mol Biol 1993;44:611-6.
-
(1993)
J Steroid Biochem Mol Biol
, vol.44
, pp. 611-616
-
-
Santner, S.J.1
Chen, S.2
Zhou, D.3
Korsunsky, Z.4
Martel, J.5
Santen, R.J.6
-
3
-
-
0032031754
-
In situ aromatization enhances breast tumor estradiol levels and cellular proliferation
-
Yue W, Wang JP, Hamilton CJ, Demers LM, Santen RJ. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res 1998;58:927-32.
-
(1998)
Cancer Res
, vol.58
, pp. 927-932
-
-
Yue, W.1
Wang, J.P.2
Hamilton, C.J.3
Demers, L.M.4
Santen, R.J.5
-
4
-
-
0029890377
-
Molecular mechanisms of estrogen carcinogenesis
-
Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36: 203-32.
-
(1996)
Annu Rev Pharmacol Toxicol
, vol.36
, pp. 203-232
-
-
Yager, J.D.1
Liehr, J.G.2
-
5
-
-
10744224293
-
Genotoxic metabolites of estradiol in breast: Potential mechanism of estradiol induced carcinogenesis
-
Yue W, Santen RJ, Wang JP, et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003;86:477-86.
-
(2003)
J Steroid Biochem Mol Biol
, vol.86
, pp. 477-486
-
-
Yue, W.1
Santen, R.J.2
Wang, J.P.3
-
6
-
-
0032887942
-
Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer
-
Nicholson RI, McClelland RA, Robertson JF, Gee JM. Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer. Endocr Relat Cancer 1999;6:373-87.
-
(1999)
Endocr Relat Cancer
, vol.6
, pp. 373-387
-
-
Nicholson, R.I.1
McClelland, R.A.2
Robertson, J.F.3
Gee, J.M.4
-
7
-
-
30944469849
-
Estrogen carcinogenesis in breast cancer
-
Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
-
(2006)
N Engl J Med
, vol.354
, pp. 270-282
-
-
Yager, J.D.1
Davidson, N.E.2
-
8
-
-
30444434216
-
Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer
-
Jordan VC. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br J Pharmacol 2006;147 Suppl 1:S269-76.
-
(2006)
Br J Pharmacol
, vol.147
, Issue.SUPPL. 1
-
-
Jordan, V.C.1
-
9
-
-
12144269500
-
Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer
-
s
-
Osborne CK, Shou J, Massarweh S, Schiff R. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 2005;11:865-70s.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 865-870
-
-
Osborne, C.K.1
Shou, J.2
Massarweh, S.3
Schiff, R.4
-
10
-
-
11244296162
-
Mechanisms of tamoxifen resistance
-
Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer 2004;11:643-58.
-
(2004)
Endocr Relat Cancer
, vol.11
, pp. 643-658
-
-
Ring, A.1
Dowsett, M.2
-
11
-
-
10744223655
-
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
-
Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081-92.
-
(2004)
N Engl J Med
, vol.350
, pp. 1081-1092
-
-
Coombes, R.C.1
Hall, E.2
Gibson, L.J.3
-
12
-
-
24744450378
-
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17
-
Goss PE, Ingle JN, Martino S, et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 2005; 97:1262-71.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1262-1271
-
-
Goss, P.E.1
Ingle, J.N.2
Martino, S.3
-
13
-
-
11444251764
-
Results of the ATAC(Arimid ex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer
-
Howell A, Cuzick J, Baum M, et al. Results of the ATAC(Arimid ex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-2.
-
(2005)
Lancet
, vol.365
, pp. 60-62
-
-
Howell, A.1
Cuzick, J.2
Baum, M.3
-
14
-
-
0035464108
-
Aromatase, aromatase inhibitors, and breast cancer
-
Brueggemeier RW. Aromatase, aromatase inhibitors, and breast cancer. Am J Ther 2001;8:333-44.
-
(2001)
Am J Ther
, vol.8
, pp. 333-344
-
-
Brueggemeier, R.W.1
-
15
-
-
0019797751
-
Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells
-
Nawata H, Bronzert D, Lippman ME. Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells. J Biol Chem 1981;256:5016-21.
-
(1981)
J Biol Chem
, vol.256
, pp. 5016-5021
-
-
Nawata, H.1
Bronzert, D.2
Lippman, M.E.3
-
16
-
-
0021333951
-
Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells
-
Vignon F, Lippman ME, Nawata H, Derocq D, Rochefort H. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. Cancer Res 1984;44:2084-8.
-
(1984)
Cancer Res
, vol.44
, pp. 2084-2088
-
-
Vignon, F.1
Lippman, M.E.2
Nawata, H.3
Derocq, D.4
Rochefort, H.5
-
17
-
-
17844398046
-
Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
-
Gutierrez MC, Detre S, Johnston S, et al. Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J Clin Oncol 2005;23: 2469-76.
-
(2005)
J Clin Oncol
, vol.23
, pp. 2469-2476
-
-
Gutierrez, M.C.1
Detre, S.2
Johnston, S.3
-
18
-
-
33745402375
-
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
-
Epub Dec 7
-
Hiscox S, Morgan L, Green TP, Barrow D, Gee J, Nicholson RI. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast Cancer Res Treat 2006;97:263-74. Epub 2005 Dec 7.
-
(2005)
Breast Cancer Res Treat 2006
, vol.97
, pp. 263-274
-
-
Hiscox, S.1
Morgan, L.2
Green, T.P.3
Barrow, D.4
Gee, J.5
Nicholson, R.I.6
-
19
-
-
4544352393
-
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells
-
Jordan NJ, Gee JM, Barrow D, Wakeling AE, Nicholson RI. Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Res Treat 2004;87:167-80.
-
(2004)
Breast Cancer Res Treat
, vol.87
, pp. 167-180
-
-
Jordan, N.J.1
Gee, J.M.2
Barrow, D.3
Wakeling, A.E.4
Nicholson, R.I.5
-
20
-
-
18844427567
-
Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells
-
Nabha SM, Glaros S, Hong M, et al. Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells. Oncogene 2005;24:3166-76.
-
(2005)
Oncogene
, vol.24
, pp. 3166-3176
-
-
Nabha, S.M.1
Glaros, S.2
Hong, M.3
-
21
-
-
0037981367
-
A mechanism of drug resistance to tamoxifen in breast cancer
-
Schafer JM, Bentrem DJ, Takei H, Gajdos C, Badve S, Jordan VC. A mechanism of drug resistance to tamoxifen in breast cancer. J Steroid Biochem Mol Biol 2002;83:75-83.
-
(2002)
J Steroid Biochem Mol Biol
, vol.83
, pp. 75-83
-
-
Schafer, J.M.1
Bentrem, D.J.2
Takei, H.3
Gajdos, C.4
Badve, S.5
Jordan, V.C.6
-
22
-
-
2942652871
-
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
-
Shou J, Massarweh S, Osborne CK, et al. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 2004;96:926-35.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 926-935
-
-
Shou, J.1
Massarweh, S.2
Osborne, C.K.3
-
23
-
-
0042232592
-
Enhanced estrogen receptor (ER) α, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation
-
Martin LA, Farmer I, Johnston SR, Ali S, Marshall C, Dowsett M. Enhanced estrogen receptor (ER) α, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation. J Biol Chem 2003;278:30458-68.
-
(2003)
J Biol Chem
, vol.278
, pp. 30458-30468
-
-
Martin, L.A.1
Farmer, I.2
Johnston, S.R.3
Ali, S.4
Marshall, C.5
Dowsett, M.6
-
24
-
-
18144387234
-
The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation
-
Sabnis GJ, Jelovac D, Long B, Brodie A. The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation. Cancer Res 2005;65:3903-10.
-
(2005)
Cancer Res
, vol.65
, pp. 3903-3910
-
-
Sabnis, G.J.1
Jelovac, D.2
Long, B.3
Brodie, A.4
-
25
-
-
25844459070
-
Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity
-
Santen RJ, Song RX, Zhang Z, et al. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr Relat Cancer 2005;12 Suppl 1:S61-73.
-
(2005)
Endocr Relat Cancer
, vol.12
, Issue.SUPPL. 1
-
-
Santen, R.J.1
Song, R.X.2
Zhang, Z.3
-
26
-
-
20644465808
-
Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole
-
Jelovac D, Sabnis G, Long BJ, Macedo L, Goloubeva OG, Brodie AM. Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole. Cancer Res 2005;65:5380-9.
-
(2005)
Cancer Res
, vol.65
, pp. 5380-5389
-
-
Jelovac, D.1
Sabnis, G.2
Long, B.J.3
Macedo, L.4
Goloubeva, O.G.5
Brodie, A.M.6
-
27
-
-
0031458548
-
Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells
-
Sun XZ, Zhou D, Chen S. Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells. J Steroid Biochem Mol Biol 1997;63: 29-36.
-
(1997)
J Steroid Biochem Mol Biol
, vol.63
, pp. 29-36
-
-
Sun, X.Z.1
Zhou, D.2
Chen, S.3
-
28
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
29
-
-
17144420079
-
Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: A microarray approach
-
Itoh T, Karlsberg K, Kijima I, et al. Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach. Mol Cancer Res 2005;3:203-18.
-
(2005)
Mol Cancer Res
, vol.3
, pp. 203-218
-
-
Itoh, T.1
Karlsberg, K.2
Kijima, I.3
-
30
-
-
27744543104
-
Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen
-
Kijima I, Itoh T, Chen S. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen. J Steroid Biochem Mol Biol 2005;97:360-8.
-
(2005)
J Steroid Biochem Mol Biol
, vol.97
, pp. 360-368
-
-
Kijima, I.1
Itoh, T.2
Chen, S.3
-
31
-
-
33751275796
-
Aromatase destabilizer: Novel action of exemestane, a food and drug administration-approved aromatase inhibitor
-
Wang X, Chen S. Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor. Cancer Res 2006;66:10281-6.
-
(2006)
Cancer Res
, vol.66
, pp. 10281-10286
-
-
Wang, X.1
Chen, S.2
-
32
-
-
23744443778
-
Adaptive hypersensitivity to estrogen: Mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment
-
Santen RJ, Song RX, Zhang Z, et al. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment. J Steroid Biochem Mol Biol 2005;95: 155-65.
-
(2005)
J Steroid Biochem Mol Biol
, vol.95
, pp. 155-165
-
-
Santen, R.J.1
Song, R.X.2
Zhang, Z.3
-
33
-
-
54749125642
-
Characterization of the weak ERα agonistic activity of exemestane [abstract 5434]
-
Masri S, Lui K, Phung S, et al. Characterization of the weak ERα agonistic activity of exemestane [abstract 5434]. Proc Am Assoc Cancer Res 2008;49:1291.
-
(2008)
Proc Am Assoc Cancer Res
, vol.49
, pp. 1291
-
-
Masri, S.1
Lui, K.2
Phung, S.3
-
34
-
-
42049120692
-
The role of amphiregulin in exemestane-resistant breast cancer cells: Evidence of an autocrine loop
-
Wang X, Masri S, Phung S, Chen S. The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop. Cancer Res 2008;68: 2259-65.
-
(2008)
Cancer Res
, vol.68
, pp. 2259-2265
-
-
Wang, X.1
Masri, S.2
Phung, S.3
Chen, S.4
-
35
-
-
38849091433
-
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
-
Massarweh S, Osborne CK, Creighton CJ, et al. Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res 2008;68:826-33.
-
(2008)
Cancer Res
, vol.68
, pp. 826-833
-
-
Massarweh, S.1
Osborne, C.K.2
Creighton, C.J.3
-
36
-
-
4644243456
-
Tamoxifen long-term treatment in vitro alters the apoptotic response of MCF-7 breast cancer cells
-
Treeck O, Zhou R, Diedrich K, Ortmann O. Tamoxifen long-term treatment in vitro alters the apoptotic response of MCF-7 breast cancer cells. Anticancer Drugs 2004;15:787-93.
-
(2004)
Anticancer Drugs
, vol.15
, pp. 787-793
-
-
Treeck, O.1
Zhou, R.2
Diedrich, K.3
Ortmann, O.4
-
37
-
-
28744431757
-
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: Implicated role of growth factor signaling and estrogen receptor coregulators
-
Schiff R, Massarweh SA, Shou J, et al. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer Chemother Pharmacol 2005;56 Suppl 1:10-20.
-
(2005)
Cancer Chemother Pharmacol
, vol.56
, Issue.SUPPL. 1
, pp. 10-20
-
-
Schiff, R.1
Massarweh, S.A.2
Shou, J.3
-
38
-
-
34548445351
-
Molecular response to aromatase inhibitor treatment in primary breast cancer
-
Mackay A, Urruticoechea A, Dixon JM, et al. Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast Cancer Res 2007;9:R37.
-
(2007)
Breast Cancer Res
, vol.9
-
-
Mackay, A.1
Urruticoechea, A.2
Dixon, J.M.3
-
39
-
-
24744443547
-
Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
-
Arpino G, Weiss H, Lee AV, et al. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 2005;97:1254-61.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1254-1261
-
-
Arpino, G.1
Weiss, H.2
Lee, A.V.3
-
40
-
-
32944482243
-
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
-
Cui X, Schiff R, Arpino G, Osborne CK, Lee AV. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 2005;23:7721-35.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7721-7735
-
-
Cui, X.1
Schiff, R.2
Arpino, G.3
Osborne, C.K.4
Lee, A.V.5
-
41
-
-
33645234316
-
Bidirectional cross talk between ERa and EGFR signalling pathways regulates tamoxifen-resistant growth
-
Britton DJ, Hutcheson IR, Knowlden JM, et al. Bidirectional cross talk between ERa and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res Treat 2006;96:131-46.
-
(2006)
Breast Cancer Res Treat
, vol.96
, pp. 131-146
-
-
Britton, D.J.1
Hutcheson, I.R.2
Knowlden, J.M.3
-
42
-
-
33846827373
-
Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models
-
Kuske B, Naughton C, Moore K, et al. Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models. Endocr Relat Cancer 2006;13:1121-33.
-
(2006)
Endocr Relat Cancer
, vol.13
, pp. 1121-1133
-
-
Kuske, B.1
Naughton, C.2
Moore, K.3
-
43
-
-
0035971181
-
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: A new model for anti-estrogen resistance
-
Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: a new model for anti-estrogen resistance. J Biol Chem 2001;276:9817-24.
-
(2001)
J Biol Chem
, vol.276
, pp. 9817-9824
-
-
Campbell, R.A.1
Bhat-Nakshatri, P.2
Patel, N.M.3
Constantinidou, D.4
Ali, S.5
Nakshatri, H.6
-
44
-
-
0029877913
-
Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
-
Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996;15:2174-83.
-
(1996)
EMBO J
, vol.15
, pp. 2174-2183
-
-
Bunone, G.1
Briand, P.A.2
Miksicek, R.J.3
Picard, D.4
-
45
-
-
0028886694
-
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
-
Kato S, Endoh H, Masuhiro Y, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995;270:1491-4.
-
(1995)
Science
, vol.270
, pp. 1491-1494
-
-
Kato, S.1
Endoh, H.2
Masuhiro, Y.3
|